Bausch Health to Announce Fourth-Quarter and Full-Year 2022 Results on Feb. 23 Pharmaceutical Investing
Avricore Health Corporate Update - Earnings Advisory 2022 and 2023 Objectives Pharmaceutical Investing
PFIZER REPORTS RECORD FULL-YEAR 2022 RESULTS AND PROVIDES FULL-YEAR 2023 FINANCIAL GUIDANCE Pharmaceutical Investing
Federal Appellate Court Rejects Controversial J&J Ploy to Dodge Talc Cancer Lawsuits Pharmaceutical Investing
Kite and Arcellx Close Agreement to Co-develop and Co-commercialize Late-stage Clinical CART-ddBCMA in Multiple Myeloma Pharmaceutical Investing
Bristol Myers Squibb Receives Positive CHMP Opinion for Reblozyl® for Adult Patients with Anemia-Associated, Non-Transfusion-Dependent Beta Thalassemia Pharmaceutical Investing
Bristol Myers Squibb Announces Positive CHMP Opinion for Once-Daily Sotyktu as a Treatment for Adults With Moderate-to-Severe Plaque Psoriasis Pharmaceutical Investing
FDA Approves KEYTRUDA® as Adjuvant Treatment Following Surgical Resection and Platinum-Based Chemotherapy for Patients With Stage IB , II, or IIIA Non-Small Cell Lung Cancer Pharmaceutical Investing
FDA Approves Abbott's Spinal Cord Stimulation for People Living with Painful Diabetic Peripheral Neuropathy Pharmaceutical Investing
Lobe Sciences, Ltd. Enters Collaborative Clinical Research Agreement with Integrative Headache Medicine of New York to Study the Effects of L-130 in the Treatment of Chronic Cluster Headache Pharmaceutical Investing
Merck Animal Health Receives U.S. FDA Approval of Expanded Indication for BRAVECTO Chews for Dogs Pharmaceutical Investing
BetterLife Announces Engagement of Bloom Burton Securities Inc. and Provides Summary of 2022 Accomplishments Pharmaceutical Investing
